tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RGEN Stock Latest News

Novo Nordisk update raises questions on Repligen approval, says Canaccord
The FlyNovo Nordisk update raises questions on Repligen approval, says Canaccord
3d ago
NVO
RGEN
Repligen price target raised to $160 from $150 at Barclays
PremiumThe Fly
Repligen price target raised to $160 from $150 at Barclays
14d ago
RGEN
Repligen’s Growth Potential: A Buy Rating Backed by Innovation and Strategic Positioning
PremiumRatings
Repligen’s Growth Potential: A Buy Rating Backed by Innovation and Strategic Positioning
15d ago
RGEN
Repligen initiated with a Buy at HSBC
PremiumThe Fly
Repligen initiated with a Buy at HSBC
15d ago
RGEN
Repligen upgraded to Outperform from In Line at Evercore ISI
PremiumThe Fly
Repligen upgraded to Outperform from In Line at Evercore ISI
24d ago
RGEN
Repligen price target raised to $205 from $204 at RBC Capital
PremiumThe FlyRepligen price target raised to $205 from $204 at RBC Capital
1M ago
RGEN
Repligen Appoints Violetta Hughes as Chief Accounting Officer
Premium
Company Announcements
Repligen Appoints Violetta Hughes as Chief Accounting Officer
1M ago
8K
RGEN
Repligen announces strategic partnership with Novasign
Premium
The Fly
Repligen announces strategic partnership with Novasign
3M ago
RGEN
Repligen’s Strong Market Position and Growth Prospects Justify Buy Rating
PremiumRatings
Repligen’s Strong Market Position and Growth Prospects Justify Buy Rating
3M ago
RGEN
Repligen’s Earnings Call Highlights Robust Growth
PremiumCompany Announcements
Repligen’s Earnings Call Highlights Robust Growth
3M ago
RGEN
Repligen Corporation Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Repligen Corporation Reports Strong Q2 2025 Growth
3M ago
RGEN
Repligen’s Strong Organic Growth and Strategic Positioning Make it a Compelling Buy
PremiumRatings
Repligen’s Strong Organic Growth and Strategic Positioning Make it a Compelling Buy
3M ago
RGEN
Repligen’s Strong Q2 Performance and Growth Prospects Justify Buy Rating
PremiumRatingsRepligen’s Strong Q2 Performance and Growth Prospects Justify Buy Rating
3M ago
RGEN
Repligen reports Q2 adjusted EPS 37c, consensus 39c
Premium
The Fly
Repligen reports Q2 adjusted EPS 37c, consensus 39c
3M ago
RGEN
Repligen sees FY25 non-GAAP EPS $1.65-$1.72, consensus $1.68
Premium
The Fly
Repligen sees FY25 non-GAAP EPS $1.65-$1.72, consensus $1.68
3M ago
RGEN
RGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
RGEN
Netflix downgraded, Intel initiated: Wall Street’s top analyst calls
PremiumThe Fly
Netflix downgraded, Intel initiated: Wall Street’s top analyst calls
3M ago
ACI
AMD
Repligen resumed with an Overweight at Stephens
PremiumThe Fly
Repligen resumed with an Overweight at Stephens
3M ago
RGEN
Repligen initiated with an Overweight at Barclays
PremiumThe Fly
Repligen initiated with an Overweight at Barclays
4M ago
RGEN
Regeneron Stock (REGN) Retreats as Lung Disease Drug Data Disappoints
PremiumMarket NewsRegeneron Stock (REGN) Retreats as Lung Disease Drug Data Disappoints
5M ago
SNY
RGEN
Repligen Holds Annual Shareholders Meeting, Key Decisions Made
Premium
Company Announcements
Repligen Holds Annual Shareholders Meeting, Key Decisions Made
5M ago
8K
RGEN
Repligen’s Strategic Growth and Resilience Drive Buy Rating with $180 Price Target
Premium
Ratings
Repligen’s Strategic Growth and Resilience Drive Buy Rating with $180 Price Target
5M ago
RGEN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >